NEWS
Clinical Leader | Can Anti-TNF Treat Post-operative Cognitive Decline? New Clinical Research Investigates

Post-operative cognitive decline (POCD) is a state in which new cognitive impairments arise in patients after a surgical procedure. It can occur in patients following surgeries to repair a hip fracture, coronary artery bypass, or other procedures. People who suffer from POCD can develop difficulty remembering things and performing daily tasks, and may possibly end […]

Cell and Gene | RNA’s Advantages Over Other Cell Therapies With Cartesian’s CSO

Dr. Michael Singer, CSO at Cartesian Therapeutics, details why RNA has advantages over other cell therapies, the company’s three RNA trials, and the therapeutic benefit of multiple modifications.

Endpoints News | Taking notes from MD Anderson and Rice University, Avenge Bio uncloaks with $45M and a slate of immunotherapies

Michael Heffernan was already the head of a biotech company focused on chronic pain, called Collegium Pharmaceutical, which he successfully brought public in 2015. But when his wife was diagnosed with ovarian cancer, he knew that was his next mission. Heffernan’s wife is doing well — but unfortunately, that isn’t the case for most patients, […]